trimegestone has been researched along with Uterine Hemorrhage in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conard, J; Hellgren, M; Kluft, C; Norris, L | 1 |
| Pornel, B; Spielmann, D | 1 |
| Koninckx, PR; Spielmann, D | 1 |
| Bouchard, P; De Cicco-Nardone, F; Garcea, N; Spielmann, D | 1 |
| Bossemeyer, R; Bouchard, P; Sitruk-Ware, R | 1 |
| Al-Azzawi, F; Thompson, J; Thompson, W; Wahab, M; Whitehead, M | 1 |
| Al-Azzawi, F; Thompson, J; Wahab, M | 1 |
| al-Azzawi, F; Dillon, J; Hirvonen, E; Magaril, C; Pornel, B; Thompson, J; van der Mooren, MJ; Wahab, M; Ylikorkala, O | 1 |
| Al-Azzawi, F; Thompson, J; Wahab, M; Whitehead, M | 1 |
1 review(s) available for trimegestone and Uterine Hemorrhage
| Article | Year |
|---|---|
Preclinical and clinical properties of trimegestone: a potent and selective progestin.
Topics: Affect; Animals; Body Weight; Central Nervous System; Chemical Phenomena; Chemistry; Depression; Drug Therapy, Combination; Endometrium; Estradiol; Female; gamma-Aminobutyric Acid; Hot Flashes; Humans; Progestins; Promegestone; Receptors, Progesterone; Sleep; Uterine Hemorrhage | 2007 |
8 trial(s) available for trimegestone and Uterine Hemorrhage
| Article | Year |
|---|---|
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.
Topics: Adult; Aged; Biomarkers; Blood Coagulation Factors; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Postmenopause; Progestins; Promegestone; Risk Factors; Thromboembolism; Uterine Hemorrhage | 2009 |
A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sleep Wake Disorders; Sweating; Uterine Hemorrhage | 2005 |
A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Uterine Hemorrhage | 2005 |
Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women.
Topics: Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Humans; Israel; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2005 |
Acceptability and patterns of uterine bleeding in sequential trimegestone-based hormone replacement therapy: a dose-ranging study.
Topics: Aged; Biopsy; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperplasia; Middle Aged; Postmenopause; Promegestone; Uterine Hemorrhage | 1999 |
The effect of submucous fibroids on the dose-dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy.
Topics: Dose-Response Relationship, Drug; Endometrium; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Middle Aged; Postmenopause; Progesterone Congeners; Promegestone; Uterine Hemorrhage; Uterine Neoplasms | 2000 |
Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
Topics: Argentina; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2001 |
The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study.
Topics: Dose-Response Relationship, Drug; Endometrium; Estrogen Replacement Therapy; Female; Humans; Incidence; Medical Records; Middle Aged; Progestins; Promegestone; Severity of Illness Index; Time Factors; Uterine Hemorrhage | 2002 |